Monoclonal Antibodies for the Treatment of Plaque Psoriasis

Prescriber - United Kingdom
doi 10.1002/psb.1790
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Infliximab for the Treatment of Plaque Psoriasis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Dimethyl Fumarate for the Treatment of Plaque Psoriasis

Prescriber
Pharmacology
2018English

Monoclonal Antibodies for the Treatment of Cancer

Anticancer Research
MedicineCancer ResearchOncology
2017English

Risankizumab for the Treatment of Plaque Psoriasis in Adults

Prescriber
Pharmacology
2019English

Tildrakizumab for the Treatment of Plaque Psoriasis in Adults

Prescriber
Pharmacology
2019English

From the Medical Board of the National Psoriasis Foundation: Treatment Targets for Plaque Psoriasis

Journal of the American Academy of Dermatology
Dermatology
2017English

The Development of Practice Guidelines for the Treatment of Severe Plaque Form Psoriasis

Archives of Dermatology
1998English

Role of Monoclonal Antibodies in the Treatment of Asthma

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Risankizumab vs. Ustekinumab for Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy